Category Archives: Past Webinars

Intellia’s Modular CRISPR/Cas9 Gene Editing Platform for the Treatment of Disease

December 4th, 2020

At Intellia, we are building a full-spectrum, product-driven biotechnology company focused on our mission of developing and commercializing potentially curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Academia or Industry? A career discussion

00

Time matters! – Why PK/PD is important for oligo development

June 10, 2020

This webinar will give an overview of how incorporating quantitative PK/PD aspects of an oligonucleotide will help you designing more informative experiments and help in translating to a human…..

Safety of Therapeutic Oligonucleotides

May 13, 2020

Patrik Andersson, Principal Scientist and RNA Therapeutics Safety Lead, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca Gothenburg…